Orrick Herrington & Sutcliffe LLP has advised San Francisco-based biopharmaceutical company Cortexyme (Nasdaq: CRTX) on its $125 million private placement of common stock. Cortexyme, Inc. (Nasdaq:…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now